Haploidentical Stem Cell Transplantation in Lymphomas—Expectations and Pitfalls

T-cell replete Haploidentical stem cell transplantation (Haplo-SCT) with Post-transplant cyclophosphamide (PT-Cy) is an emerging therapeutic option for patients with advanced relapsed or refractory lymphoma. The feasibility of this platform is supported by several retrospective studies showing a tox...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariotti, Jacopo, Bramanti, Stefania, Santoro, Armando, Castagna, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695017/
https://www.ncbi.nlm.nih.gov/pubmed/33171719
http://dx.doi.org/10.3390/jcm9113589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695017/
https://www.ncbi.nlm.nih.gov/pubmed/33171719
http://dx.doi.org/10.3390/jcm9113589

Ejemplares similares